FDA NDC Directory · JSON-LD · Markdown

Flunisolide

NDC 50742-317 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerIngenus Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA207802
Dosage form / routeSOLUTION · NASAL
Active ingredientsFLUNISOLIDE (.25 mg/mL)
Marketing started20220623
Package count1

External sources

Source: openFDA. Public-domain (CC0).